Practice
Featured experience
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
First Eagle Investments majority investment from Genstar Capital
We are advising First Eagle Investments on the transaction
Prosus €4.1 billion recommended tender offer for Just Eat Takeaway.com
We are advising Prosus on the transaction
Meritage Group sale of interest in TowerPoint Infrastructure Partners
We are advising Meritage Group on the transaction
Williams $325 million acquisition of Rimrock gathering and processing system
We advised Williams on the transaction
Nidec ¥257 billion tender offer for Makino Milling Machine
We are advising Nidec on the transaction
TE Connectivity acquisition of Richards Manufacturing
We are advising TE Connectivity on the transaction
Morrison Express Worldwide acquisition by SG Holdings
We are advising Morrison Express Holdings as the seller
McKesson $850 million acquisition of controlling interest in PRISM Vision
We are advising McKesson on the transaction
Elliott Investment Management sale of Prosperity Life to JAB Holding Company
We are advising Elliott on the sale
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition